Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefano Pileri

Showing results (61-70 of 176) with videos related to

Pageof 18
Sort By:
The Journal of Pathology|January 21, 2003
High-throughput tissue microarray analysis of G1-cyclin alterations in classical Hodgkin's lymphoma indicates overexpression of cyclin E1Alexandar Tzankov, Annette Zimpfer, Alessandro Lugli, et al.
Hemasphere|February 27, 2023
Unmet Clinical Needs and Management Recommendations for Blastic Plasmacytoid Dendritic Cell Neoplasm: A Consensus-based Position Paper From an Ad Hoc International Expert PanelLivio Pagano, Pier Luigi Zinzani, Stefano Pileri, et al.
Leukemia & Lymphoma|April 21, 2011
Lenalidomide monotherapy for relapsed/refractory peripheral T-cell lymphoma not otherwise specifiedPier Luigi Zinzani, Cinzia Pellegrini, Alessandro Broccoli, et al.
Leukemia & Lymphoma|June 14, 2003
Extranodal marginal zone B-cell lymphoma of MALT-type of the lung: single-center experience with 12 patientsPier Luigi Zinzani, Monica Tani, Annalisa Gabriele, et al.
Virchows Archiv : an International Journal of Pathology|June 3, 2017
B-cell lymphomas with discordance between pathological features and clinical behaviorLaurence de Leval, Christiane Copie-Bergman, Andreas Rosenwald, et al.
Leukemia & Lymphoma|October 29, 2005
Value of oxaliplatin treatment in heavily pretreated patients with non-Hodgkin's lymphomaLapo Alinari, Gerardo Musuraca, Monica Tani, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 6, 2011
Primary bone lymphoma: evaluation of chemoimmunotherapy as front-line treatment in 21 patientsCinzia Pellegrini, Letizia Gandolfi, Federica Quirini, et al.
The Journal of Biological Chemistry|November 6, 2013
Protein arginine methyltransferase 5 (PRMT5) inhibition induces lymphoma cell death through reactivation of the retinoblastoma tumor suppressor pathway and polycomb repressor complex 2 (PRC2) silencingJihyun Chung, Vrajesh Karkhanis, Sookil Tae, et al.
Blood|July 2, 2002
The expression pattern of c-mpl in megakaryocytes correlates with thrombotic risk in essential thrombocythemiaLuciana Teofili, Francesco Pierconti, Annalaura Di Febo, et al.
Leukemia & Lymphoma|November 9, 2007
VNCOP-B plus rituximab in the treatment of diffuse large B-cell lymphoma in the elderlyMariapaola Fina, Monica Tani, Vittorio Stefoni, et al.
Pageof 18

Showing results (61-70 of 176) with videos related to

Sort By:
Pageof 18
The Journal of Pathology|January 21, 2003
High-throughput tissue microarray analysis of G1-cyclin alterations in classical Hodgkin's lymphoma indicates overexpression of cyclin E1Alexandar Tzankov, Annette Zimpfer, Alessandro Lugli, et al.
Hemasphere|February 27, 2023
Unmet Clinical Needs and Management Recommendations for Blastic Plasmacytoid Dendritic Cell Neoplasm: A Consensus-based Position Paper From an Ad Hoc International Expert PanelLivio Pagano, Pier Luigi Zinzani, Stefano Pileri, et al.
Leukemia & Lymphoma|April 21, 2011
Lenalidomide monotherapy for relapsed/refractory peripheral T-cell lymphoma not otherwise specifiedPier Luigi Zinzani, Cinzia Pellegrini, Alessandro Broccoli, et al.
Leukemia & Lymphoma|June 14, 2003
Extranodal marginal zone B-cell lymphoma of MALT-type of the lung: single-center experience with 12 patientsPier Luigi Zinzani, Monica Tani, Annalisa Gabriele, et al.
Virchows Archiv : an International Journal of Pathology|June 3, 2017
B-cell lymphomas with discordance between pathological features and clinical behaviorLaurence de Leval, Christiane Copie-Bergman, Andreas Rosenwald, et al.
Leukemia & Lymphoma|October 29, 2005
Value of oxaliplatin treatment in heavily pretreated patients with non-Hodgkin's lymphomaLapo Alinari, Gerardo Musuraca, Monica Tani, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 6, 2011
Primary bone lymphoma: evaluation of chemoimmunotherapy as front-line treatment in 21 patientsCinzia Pellegrini, Letizia Gandolfi, Federica Quirini, et al.
The Journal of Biological Chemistry|November 6, 2013
Protein arginine methyltransferase 5 (PRMT5) inhibition induces lymphoma cell death through reactivation of the retinoblastoma tumor suppressor pathway and polycomb repressor complex 2 (PRC2) silencingJihyun Chung, Vrajesh Karkhanis, Sookil Tae, et al.
Blood|July 2, 2002
The expression pattern of c-mpl in megakaryocytes correlates with thrombotic risk in essential thrombocythemiaLuciana Teofili, Francesco Pierconti, Annalaura Di Febo, et al.
Leukemia & Lymphoma|November 9, 2007
VNCOP-B plus rituximab in the treatment of diffuse large B-cell lymphoma in the elderlyMariapaola Fina, Monica Tani, Vittorio Stefoni, et al.
Pageof 18